Morepen Laboratories secures massive Rs 200cr funding to revolutionise medical devices and API market
Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful subscription of a Qualified Institutional Placement (QIP) for Rs. 200 crore. This strategic move ... Read More
Morepen Laboratories secures FDA approval for Fexofinadine (Allegra)
Morepen Laboratories Limited has secured approval from the US Food and Drug Administration (FDA) for its anti-allergy drug Fexofinadine Hydrochloride, which it expects to begin ... Read More
Morepen Laboratories spins out medical devices business
Morepen Laboratories Limited said that it has separated its point of care (POC) medical devices business into a newly formed fully-owned subsidiary called Morepen Devices ... Read More
Morepen Laboratories produces test batch of Sputnik V Covid vaccine
Morepen Laboratories and the Russian Direct Investment Fund (RDIF) announced the production of the test batch of the Russian Sputnik V Covid vaccine in an ... Read More